loading
Schlusskurs vom Vortag:
$6.75
Offen:
$6.74
24-Stunden-Volumen:
1.29M
Relative Volume:
0.46
Marktkapitalisierung:
$739.25M
Einnahmen:
$42.51M
Nettoeinkommen (Verlust:
$-116.49M
KGV:
-6.0893
EPS:
-1.12
Netto-Cashflow:
$-120.82M
1W Leistung:
+0.74%
1M Leistung:
+37.22%
6M Leistung:
+124.34%
1J Leistung:
-30.76%
1-Tages-Spanne:
Value
$6.68
$7.105
1-Wochen-Bereich:
Value
$6.36
$7.105
52-Wochen-Spanne:
Value
$1.03
$12.02

Tango Therapeutics Inc Stock (TNGX) Company Profile

Name
Firmenname
Tango Therapeutics Inc
Name
Telefon
(857) 320-4900
Name
Adresse
201 BROOKLINE AVENUE, BOSTON
Name
Mitarbeiter
155
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
TNGX's Discussions on Twitter

Vergleichen Sie TNGX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TNGX
Tango Therapeutics Inc
6.82 731.66M 42.51M -116.49M -120.82M -1.12
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-07-17 Eingeleitet Jefferies Buy
2024-04-04 Eingeleitet Cantor Fitzgerald Overweight
2024-02-12 Eingeleitet Piper Sandler Overweight
2023-12-08 Eingeleitet B. Riley Securities Buy
2022-10-20 Hochstufung H.C. Wainwright Neutral → Buy
2021-09-20 Eingeleitet SVB Leerink Outperform
Alle ansehen

Tango Therapeutics Inc Aktie (TNGX) Neueste Nachrichten

pulisher
09:00 AM

What are analysts’ price targets for Tango Therapeutics Inc. in the next 12 monthsNavigate market shifts with confidence - jammulinksnews.com

09:00 AM
pulisher
07:50 AM

Should I hold or sell Tango Therapeutics Inc. stock in 2025Capitalize on high-yield stocks early - jammulinksnews.com

07:50 AM
pulisher
07:14 AM

Will Tango Therapeutics Inc. stock benefit from interest rate changesFree Best Performing Stock Suggestions - Newser

07:14 AM
pulisher
06:37 AM

Tango Therapeutics Inc. Company Revenue and Profit Trends: A Deep DiveFree Stock Trading Signals - Newser

06:37 AM
pulisher
04:59 AM

Can Tango Therapeutics Inc. stock recover from recent declineSolid Return Trade Selections - Newser

04:59 AM
pulisher
Jul 25, 2025

What drives Tango Therapeutics Inc. stock priceMassive portfolio appreciation - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Will Tango Therapeutics Inc. stock benefit from AI tech trendsSuperior capital gains - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Is Tango Therapeutics Inc. a good long term investmentPhenomenal investment performance - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Tango Therapeutics Inc. stockExplosive portfolio gains - Autocar Professional

Jul 24, 2025
pulisher
Jul 22, 2025

Tango Therapeutics Inc. Stock Analysis and ForecastMarket-beating returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Optimistic Investors Push Tango Therapeutics, Inc. (NASDAQ:TNGX) Shares Up 31% But Growth Is Lacking - 富途牛牛

Jul 22, 2025
pulisher
Jul 22, 2025

Tango Therapeutics to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025 - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

Tango Therapeutics Earnings Alert: Q2 2025 Results Coming August 5 Without Investor Call - Stock Titan

Jul 22, 2025
pulisher
Jul 19, 2025

How Tango Therapeutics Inc. stock performs during market volatilityFree Consultation - Newser

Jul 19, 2025
pulisher
Jul 18, 2025

How high can Tango Therapeutics Inc. stock price go in 2025Daily Volume Leaders - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Can Tango Therapeutics Inc Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com

Jul 17, 2025
pulisher
Jul 16, 2025

Does Tango Therapeutics (TNGX) Have the Potential to Rally 75.89% as Wall Street Analysts Expect? - MSN

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Tango Therapeutics Inc. stock price move sharplySolid Return Trade Selections - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Tango Therapeutics Inc. stock attracts strong analyst attentionFree Capital Growth Strategies - Newser

Jul 15, 2025
pulisher
Jul 09, 2025

Tango Therapeutics (TNGX) Soars 5.96% on Strong Q2 Earnings - AInvest

Jul 09, 2025

Finanzdaten der Tango Therapeutics Inc-Aktie (TNGX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Tango Therapeutics Inc-Aktie (TNGX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Barry Douglas
General Counsel
Feb 05 '25
Sale
3.16
2,556
8,081
66,014
Beckman Daniella
Chief Financial Officer
Feb 04 '25
Sale
2.99
4,284
12,801
154,232
Beckman Daniella
Chief Financial Officer
Feb 05 '25
Sale
3.16
3,948
12,481
150,284
Crystal Adam
See Remarks
Feb 04 '25
Sale
2.99
7,432
22,207
165,061
Crystal Adam
See Remarks
Feb 05 '25
Sale
3.16
6,851
21,659
158,210
Weber Barbara
Chief Executive Officer
Feb 04 '25
Sale
2.99
9,778
29,217
1,631,264
Weber Barbara
Chief Executive Officer
Feb 05 '25
Sale
3.16
9,013
28,494
1,622,251
Rothenberg Mace
Director
Nov 18 '24
Buy
3.78
10,000
37,800
31,250
Rothenberg Mace
Director
Nov 14 '24
Buy
3.62
10,000
36,200
21,250
EcoR1 Capital, LLC
10% Owner
Nov 06 '24
Sale
3.28
1,494,558
4,896,023
11,836,178
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Kapitalisierung:     |  Volumen (24h):